All News

    From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

    December 10th 2025, 10:00pm

    Article

    Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient advocacy.

    Momelotinib Combo is Safe and Helps Ease Symptoms in Myelofibrosis

    December 10th 2025, 9:48pm

    Article

    Nuvisertib plus momelotinib is safe and generated improvements in symptom burden, spleen volume, and anemia outcomes in relapsed/refractory myelofibrosis.

    Giredestrant Improves Outcomes in ER+/HER2– Breast Cancer

    December 10th 2025, 7:39pm

    Article

    Giredestrant generated improved outcomes over standard endocrine therapy in patients with ER+/HER2–, medium- and high-risk early breast cancer.

    Trodelvy Not Associated With Significant Progression Improvements in HR+/HER2– mBC

    December 10th 2025, 6:05pm

    Article

    Progression-free survival was not statistically significant with Trodelvy versus chemotherapy as first-line treatment in HR+/HER2– metastatic breast cancer.

    Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

    December 10th 2025, 2:00pm

    Video

    Emmy-winning journalist and author, Suleika Jaouad, delivered the keynote address at the inaugural Blood Cancer Heroes event.

    Off-The-Shelf CAR-T KLN-1010 Associated With Deep Responses in R/R Myeloma

    December 10th 2025, 12:12am

    Article

    KLN-1010 was associated with deep, ongoing minimal residual disease (MRD)–negative responses in multiple myeloma.

    A Closet Full of Boobs and the Thought That Caught Me by Surprise

    December 9th 2025, 10:00pm

    Article

    After cancer, even your closet tells a story you never imagined living. One quiet afternoon, that story took a hilarious and unexpected turn.

    Yescarta Shows Durable Responses and Manageable Safety in Real-World R/R FL

    December 9th 2025, 9:10pm

    Article

    Real-world treatment with Yescarta demonstrated durable responses and manageable safety in patients with relapsed/refractory follicular lymphoma.

    Dexamethasone May Ease Severe Neurotoxicity With Yescarta in LBCL

    December 9th 2025, 6:10pm

    Article

    Dexamethasone before Yescarta reduced the severity of ICANS but did not change how often ICANS or CRS occurred in patients with LBCL.

    New Data Support Pelabresib Combination in Untreated Myelofibrosis

    December 9th 2025, 5:29pm

    Article

    Pelabresib plus Jakafi delivered stronger, clinically meaningful benefits versus Jakafi alone for people with untreated myelofibrosis.